The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1288-1297

  Day, Nicholas P J ^a,b,d   Hien, Tran Tinh ^a   Schollaardt, Tineke ^c   Loc, Pham Phu ^a   Van Chuong, Ly ^a   Chau, Tran Thi Hong ^a   Mai, Nguyen Thi Hoang ^a   Phu, Nguyen Hoan ^a   Sinh, Dinh Xuan ^a   White, Nicholas J ^a,b   Ho, May ^c  

^a Centre for Tropical Diseases Vietnam   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; PARASITEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTOZOAL INFECTION; SHOCK;

EID: 0033370714     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315016     Document Type: Article

References (28)

1. Kern P, Hemmer CJ, Van Damme J, Gross HJ, Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989; 87:139-43.
2. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320:1586-91.
3. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336:1201-4.
4. Karunaweera N, Grau G, Gamage P, Carter R, Mendis K. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992; 89:3200-3.
5. Ho M, White NJ. Molecular mechanisms of cytoadherence in malaria. Am J Physiol: Cell 1999; 276:C1231-42.
6. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, Banchereau J. High levels of circulating IL-10 in human malaria. Clin Exp Immunol 1994; 95:300-3.
7. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK. Interleukin-10 inhibits tumor necrosis factor production hut not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis 1995; 172:838-44.
8. Ho M, Schollaardt T, Snape S, Looareesuwan S, Suntharasamai P, White NJ. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J Infect Dis 1998; 178:520-5.
9. Mordmuller BG, Metzger WG, Juillard P et al. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 1997; 8:29-35.
10. Kurtzhals JA, Adabayeri V, Goka BQ, et al. Low plasma concentrations of interleukin 10 in were malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998; 351:1768-72.
11. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemía in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999; 179:279-82.
12. Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335:76-83.
13. Rockett K, Awburn M, Rockett E, Cowden W, Clark I. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 1994; 16:243-9.
14. Taylor AM, Day NP, Sinh DX, et al. Reactive nitrogen intermediates and outcome in severe adult malaria. Trans R Soc Trop Med Hyg 1998; 92:170-5.
15. Box G, Cox D. An analysis of transformations. J Royal Stat Soc Ser B 1964; 26:211-52.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-45.
17. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66:101-95.
18. Wickramasinghe SN, Phillips RF., Looareesuwan S, Warrell DA, Hughes M. The bone marrow in human cerebral malaria: parasite sequestration within sinusoids. Br J Haematol 1987; 66:295-306.
19. Thijs A, Thijs LG. Pathogenesis of renal failure in sepsis. Kidney Int Suppl 1998; 66:534-7.
20. Stone W, Hanchett J, Knepshieid J. Acute renal insufficiency due to falciparum malaria. Review of 42 cases. Arch Int Med 1972; 129:620-28.
21. Trang TT, Phu NH, Vinh H, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 1992; 15:874-80.
22. Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol 1998; 18:505-18.
23. Kern P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992; 166:930-4.
24. Deloron P, Roux Lombard P, Ringwald P, et al. Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria. Eur Cytokine Netw 1994; 5:331-6.
25. Jakobsen PH, McKay V. Morris-Jones SD, et al. Increased concentrations of interleukin-6 and interlenkin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein 1 in Gambian children with cerebral malaria. Infect Immun 1994; 62:4374-9.
26. Girardin E, Roux-Lombard P, Grau GE, et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 1992; 76:20-3.
27. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL., Lowry-SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-49.
28. Mohler KM, Torrance CS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors arc effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 152:1548-61.